Trending Topic

4 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

Welcome to the latest edition of touchREVIEWS in Respiratory & Pulmonary Diseases. As we continually strive to deliver cutting-edge research and insightful commentary, this issue is no exception, featuring a diverse array of articles that illuminate both emerging treatments and evolving practices within the field of respiratory and pulmonary medicine. We begin with a compelling […]

CME Accredited Learning

Our accredited content is designed to impact patient health outcomes, by ensuring that it provides you with a learning experience that will positively impact your clinical practice, based on adult learning preferences and intuitive instructional design. All activities are developed in collaboration with leading faculty and education partners.

touchRESPIRATORY

Speciality Filter

Select Specialty or Clinical Area

Clear All
Update Filters
Close Popup
99 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchCLINICAL PERSPECTIVES
Dr Helena Yu, Dr Antonio Passaro, Dr Aaron Lisberg, Dr Sara Pilotto, Ms Jackie Fenemore, Prof. Egbert Smit

Experts provide insights on tailoring treatment in patients with EGFR-mutant and wildtype NSCLC.

39 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchMDT
Dr Lizza Hendriks, Dr Jacob Sands, Prof. Suresh Senan

A multidisciplinary team discusses the role of immune checkpoint inhibitors (ICIs) in limited-stage small cell lung cancer (LS-SCLC).

55 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchMDT
Dr Xiuning Le, Dr Christine Argento, Dr Sandra Cuellar, Ms Stephanie McDonald, Prof. Albrecht Stenzinger

A multidisciplinary team of specialists discuss the use of targeted therapies for NSCLC with MET alterations.

34 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchIN CONVERSATION
Prof. Jean-Luc Vachiéry, Prof. Manreet Kanwar

Watch two experts discuss the diagnosis, risk stratification and treatment of pulmonary arterial hypertension.

41 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchPANEL DISCUSSION
Dr Razelle Kurzrock, Dr Lyudmila Bazhenova, Dr Ignacio Wistuba

Two oncologists and a pathologist discuss the implications of HER2 targeting in solid tumours, with a focus on NSCLC.

37 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchIN CONVERSATION
Prof. Enriqueta Felip, Prof. Keith Kerr

An oncologist and a pathologist discuss HER2 testing and treatments for HER2-altered NSCLC.

33 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked

Prof. Wakelee discusses the latest evidence on immunotherapy for early-stage, resectable NSCLC.

31 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchEXPERT OPINIONS
Dr Michael Perch, Dr Howard J Huang, Dr Aldo Iacono

Three experts discuss the pathogenesis, diagnosis and treatment for bronchiolitis obliterans syndrome (BOS).

15 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked

A medical oncologist shares her insights on the current treatments for LS-SCLC and the remaining unmet needs

Society & Congress Partners

touchRESPIRATORY is proud to partner with leading medical societies and congresses from around the world to bring you news and insight from virtual and live events

View All
16 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked

An allergist shares her expert insights on the latest guidance for the diagnosis and management of food allergies, including the role of novel diagnostic tools and emerging therapies in clinical practice.

34 minutes
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked

Dr Rebecca Heist discusses emerging antibody-drug conjugates for the second-line treatment of patients with advanced non-small cell lung cancer.

16 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked

An allergist shares her expert insights and guidance on key clinical questions around the changing paradigm in the diagnosis and management of pet allergies.

34 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchEXPERT OPINIONS
Dr Efrem Eren, Dr Nirmala Gonsalves, Dr Jamal Hayat

Three experts discuss the challenges related to recognizing, diagnosing and treating patients with eosinophilic oesophagitis (EoE) and highlight how advances in diagnostic tools and emerging treatments may impact future care.

18 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked

Dr Balazs Halmos offers his perspective on immunotherapy for the treatment of squamous cell lung cancer.

38 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked

Two lung cancer specialists discuss the current recommendations for biomarker testing and the latest data on MET inhibitors for the management of patients with MET alterations.

32 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchEXPERT OPINIONS
Dr Anna Blakney, Prof. Dr. med. Oliver Cornely, Prof. Ann R Falsey

Leading experts explore mRNA vaccine platforms for respiratory viruses, including their design, clinical application and future prospects.

39 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchPANEL DISCUSSION
Prof. Biree Andemariam, Prof. Modupe Idowu, Prof. Mark C Walters

Three experts discuss the management of complications of sickle cell disease, as well as recent advances in therapy.

32 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked

A leading expert discusses the current landscape and future perspectives of immune checkpoint inhibitors for the treatment of NSCLC

Load More...

All touchIME CME activities are accredited. Learners can claim ACCME, ANCC, ACPE or EBAC credits upon completion of the activities. This content is for healthcare professionals only.

Close Popup